Cigna Group Files 8-K with Financial Updates

Ticker: CI · Form: 8-K · Filed: 2024-08-01T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Cigna Group dropped its latest 8-K on Aug 1st - check the financials!

AI Summary

On August 1, 2024, The Cigna Group filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, providing an update on the company's performance for the period ending August 1, 2024.

Why It Matters

This filing provides investors with crucial, up-to-date financial information and operational details for The Cigna Group, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not inherently introduce new risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report the Results of Operations and Financial Condition, along with Financial Statements and Exhibits of The Cigna Group.

When was this 8-K report filed?

This 8-K report was filed on August 1, 2024.

What is the principal executive office address for The Cigna Group?

The principal executive office address for The Cigna Group is 900 Cottage Grove Road, Bloomfield, Connecticut 06002.

What is the Commission File Number for The Cigna Group?

The Commission File Number for The Cigna Group is 001-38769.

What jurisdiction is The Cigna Group incorporated in?

The Cigna Group is incorporated in Delaware.

From the Filing

0000950159-24-000233.txt : 20240801 0000950159-24-000233.hdr.sgml : 20240801 20240801061516 ACCESSION NUMBER: 0000950159-24-000233 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240801 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 241164009 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 cigna8k.htm THE CIGNA GROUP FORM 8-K The Cigna Group Form 8-K Earnings Release false 0001739940 0001739940 2024-08-01 2024-08-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549   FORM 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the   Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) August 1, 2024   The Cigna Group   (Exact name of registrant as specified in its charter)   Delaware (State or other jurisdiction of   incorporation) 001-38769 (Commission File Number) 82-4991898 (IRS Employer Identification No.)   900 Cottage Grove Road Bloomfield , Connecticut 06002   (Address of principal executive offices) (Zip Code)   Registrant’s telephone number, including area code:   ( 860 ) 226-6000   Not Applicable   (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐               Item 2.02 Results of Operations and Financial Condition.   On August 1, 2024, The Cigna Group issued a press release announcing results for the three months ended June 30, 2024. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.   This information shall not be deemed “filed” for purposes of Section 18 of the Securities Ex

View on Read The Filing